1 month Aquestive Therapeutics (NASDAQ:AQST) Price Target Increased to $13.00 by Analysts at Leerink PartnersMarketBeat
Leerink Partners raised their price objective on shares of Aquestive Therapeutics from $12.00 to $13.00 and gave the stock an “outperform” rating in a research report on Friday.
X